特异性抗体免疫组化法检测EGFR突变价值的meta分析

BACKGROUND AND OBJECTIVE: It has been proven that epidermal growth factor receptor (EGFR) mutation is the most important predictive factor for determining the effect of EGFR tyrosine kinase inhibitors (TKIs) applied to non-small cell lung cancer (NSCLC) patients. The patients with EGFR mutations res...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000101/
https://www.ncbi.nlm.nih.gov/pubmed/24949684
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.03

Ejemplares similares